• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Performance of methods for handling missing categorical covariate data in population pharmacokinetic analyses.缺失类别协变量数据在群体药代动力学分析中处理方法的性能评估。
AAPS J. 2012 Sep;14(3):601-11. doi: 10.1208/s12248-012-9373-2. Epub 2012 May 31.
2
Approaches for missing covariate data in logistic regression with MNAR sensitivity analyses.具有 MAR 敏感性分析的逻辑回归中缺失协变量数据的处理方法。
Biom J. 2020 Jul;62(4):1025-1037. doi: 10.1002/bimj.201900117. Epub 2020 Jan 20.
3
Imputation of missing covariate in randomized controlled trials with a continuous outcome: Scoping review and new results.缺失协变量在随机对照试验中连续结果的推断:范围综述和新结果。
Pharm Stat. 2020 Nov;19(6):840-860. doi: 10.1002/pst.2041. Epub 2020 Jun 8.
4
Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study.预后建模研究中缺失协变量数据处理技术的比较:一项模拟研究。
BMC Med Res Methodol. 2010 Jan 19;10:7. doi: 10.1186/1471-2288-10-7.
5
Data Missing Not at Random in Mobile Health Research: Assessment of the Problem and a Case for Sensitivity Analyses.移动健康研究中的数据缺失非随机:问题评估与敏感性分析案例。
J Med Internet Res. 2021 Jun 15;23(6):e26749. doi: 10.2196/26749.
6
Empirical Likelihood in Nonignorable Covariate-Missing Data Problems.非ignorable协变量缺失数据问题中的经验似然
Int J Biostat. 2017 Apr 20;13(1):/j/ijb.2017.13.issue-1/ijb-2016-0053/ijb-2016-0053.xml. doi: 10.1515/ijb-2016-0053.
7
Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors.Heckman 插补模型用于二分类或连续 MNAR 结局和 MAR 预测因子。
BMC Med Res Methodol. 2018 Aug 31;18(1):90. doi: 10.1186/s12874-018-0547-1.
8
Covariate detection in population pharmacokinetics using partially linear mixed effects models.使用部分线性混合效应模型在群体药代动力学中进行协变量检测。
Pharm Res. 2005 Apr;22(4):541-9. doi: 10.1007/s11095-005-2492-z. Epub 2005 Apr 7.
9
Improving estimation efficiency for regression with MNAR covariates.提高具有 MAR 协变量的回归估计效率。
Biometrics. 2020 Mar;76(1):270-280. doi: 10.1111/biom.13131. Epub 2019 Nov 7.
10
Recovery of information from multiple imputation: a simulation study.从多重填补中恢复信息:一项模拟研究。
Emerg Themes Epidemiol. 2012 Jun 13;9(1):3. doi: 10.1186/1742-7622-9-3.

引用本文的文献

1
Population pharmacokinetics of pyrazinamide and isoniazid in plasma and cerebrospinal fluid from South African adults with tuberculous meningitis.南非结核性脑膜炎成年患者血浆和脑脊液中吡嗪酰胺及异烟肼的群体药代动力学
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0009925. doi: 10.1128/aac.00099-25. Epub 2025 Jul 1.
2
Assessing the Impact of Multiple Imputation Algorithms on Pharmacokinetic Model Performance: A Simulation-Based Study.评估多重填补算法对药代动力学模型性能的影响:一项基于模拟的研究。
AAPS J. 2025 Apr 17;27(4):77. doi: 10.1208/s12248-025-01066-1.
3
Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi-physiologic population pharmacokinetic approach.SLC22A1基因多态性对韩国人群中氯胍药代动力学的影响:一种半生理群体药代动力学方法。
Clin Transl Sci. 2024 Dec;17(12):e70103. doi: 10.1111/cts.70103.
4
Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.健康非吸烟志愿者氯氮平和去甲氯氮平的半生理药代动力学模型:种族和遗传的影响。
CNS Drugs. 2024 Jul;38(7):571-581. doi: 10.1007/s40263-024-01092-1. Epub 2024 Jun 5.
5
Covariate modeling in pharmacometrics: General points for consideration.药物代谢动力学中的协变量建模:一般注意事项。
CPT Pharmacometrics Syst Pharmacol. 2024 May;13(5):710-728. doi: 10.1002/psp4.13115. Epub 2024 Apr 2.
6
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.高剂量异烟肼缺乏对 katG 突变介导的耐异烟肼结核病的早期杀菌活性:一项随机、Ⅱ期临床试验。
Am J Respir Crit Care Med. 2024 Aug 1;210(3):343-351. doi: 10.1164/rccm.202311-2004OC.
7
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.评估小儿结核病剂量指南:基于模型的个体数据合并分析。
PLoS Med. 2023 Nov 21;20(11):e1004303. doi: 10.1371/journal.pmed.1004303. eCollection 2023 Nov.
8
Pharmacokinetics of Efavirenz 600mg in Combination with Rifampicin in Chinese HIV/TB Co-Infection Patients.600毫克依非韦伦与利福平联合用药在中国HIV/TB合并感染患者中的药代动力学
Infect Drug Resist. 2023 Jul 17;16:4659-4666. doi: 10.2147/IDR.S415749. eCollection 2023.
9
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.标准剂量与高剂量异烟肼治疗耐多药结核病的药代动力学。
J Antimicrob Chemother. 2022 Aug 25;77(9):2489-2499. doi: 10.1093/jac/dkac188.
10
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.南非艾滋病毒感染者多替拉韦血浆暴露的药物遗传学。
J Infect Dis. 2022 Nov 1;226(9):1616-1625. doi: 10.1093/infdis/jiac174.

本文引用的文献

1
Piraña and PCluster: a modeling environment and cluster infrastructure for NONMEM.Piraña 和 PCluster:NONMEM 的建模环境和集群基础设施。
Comput Methods Programs Biomed. 2011 Jan;101(1):72-9. doi: 10.1016/j.cmpb.2010.04.018. Epub 2010 Jun 2.
2
Missing data analysis: making it work in the real world.缺失数据分析:使其在现实世界中发挥作用。
Annu Rev Psychol. 2009;60:549-76. doi: 10.1146/annurev.psych.58.110405.085530.
3
CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure and higher risk of severe hematologic toxicity.CYP2C9和CYP2C19多态性形式与因迪舒仑暴露增加及严重血液学毒性风险较高相关。
Clin Cancer Res. 2007 May 15;13(10):2970-6. doi: 10.1158/1078-0432.CCR-06-2978.
4
Simulation of correlated continuous and categorical variables using a single multivariate distribution.使用单一多元分布对相关连续变量和分类变量进行模拟。
J Pharmacokinet Pharmacodyn. 2006 Dec;33(6):773-94. doi: 10.1007/s10928-006-9033-1. Epub 2006 Oct 12.
5
Pharmacogenetic screening of CYP3A and ABCB1 in relation to population pharmacokinetics of docetaxel.多西他赛群体药代动力学相关的CYP3A和ABCB1基因检测
Clin Cancer Res. 2006 Oct 1;12(19):5786-93. doi: 10.1158/1078-0432.CCR-05-2649.
6
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.大剂量输注疗法后癌症患者甲氨蝶呤和7-羟基甲氨蝶呤清除的决定因素
Br J Clin Pharmacol. 2006 Jul;62(1):71-80. doi: 10.1111/j.1365-2125.2005.02513.x.
7
Quantitative effect of gender, age, liver function, and body size on the population pharmacokinetics of Paclitaxel in patients with solid tumors.性别、年龄、肝功能和体型对实体瘤患者中紫杉醇群体药代动力学的定量影响。
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2150-7. doi: 10.1158/1078-0432.CCR-05-2069.
8
Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.依法韦仑在未经筛选的HIV-1感染个体队列中的群体药代动力学。
Clin Pharmacokinet. 2005;44(8):849-61. doi: 10.2165/00003088-200544080-00006.
9
Maximum likelihood methods for nonignorable missing responses and covariates in random effects models.随机效应模型中不可忽略的缺失响应和协变量的最大似然方法。
Biometrics. 2003 Dec;59(4):1140-50. doi: 10.1111/j.0006-341x.2003.00131.x.
10
Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.奈韦拉平在未筛选的HIV-1感染个体队列中的群体药代动力学。
Br J Clin Pharmacol. 2002 Oct;54(4):378-85. doi: 10.1046/j.1365-2125.2002.01657.x.

缺失类别协变量数据在群体药代动力学分析中处理方法的性能评估。

Performance of methods for handling missing categorical covariate data in population pharmacokinetic analyses.

机构信息

Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, the Netherlands.

出版信息

AAPS J. 2012 Sep;14(3):601-11. doi: 10.1208/s12248-012-9373-2. Epub 2012 May 31.

DOI:10.1208/s12248-012-9373-2
PMID:22648902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3385822/
Abstract

In population pharmacokinetic analyses, missing categorical data are often encountered. We evaluated several methods of performing covariate analyses with partially missing categorical covariate data. Missing data methods consisted of discarding data (DROP), additional effect parameter for the group with missing data (EXTRA), and mixture methods in which the mixing probability was fixed to the observed fraction of categories (MIX(obs)), based on the likelihood of the concentration data (MIX(conc)), or combined likelihood of observed covariate data and concentration data (MIX(joint)). Simulations were implemented to study bias and imprecision of the methods in datasets with equal-sized and unbalanced category ratios for a binary covariate as well as datasets with non-random missingness (MNAR). Additionally, the performance and feasibility of implementation was assessed in two real datasets. At either low (10%) or high (50%) levels of missingness, all methods performed similarly well. Performance was similar for situations with unbalanced datasets (3:1 covariate distribution) and balanced datasets. In the MNAR scenario, the MIX methods showed a higher bias in the estimation of CL and covariate effect than EXTRA. All methods could be applied to real datasets, except DROP. All methods perform similarly at the studied levels of missingness, but the DROP and EXTRA methods provided less bias than the mixture methods in the case of MNAR. However, EXTRA was associated with inflated type I error rates of covariate selection, while DROP handled data inefficiently.

摘要

在群体药代动力学分析中,经常会遇到缺失的分类数据。我们评估了几种方法,用于对部分缺失的分类协变量数据进行协变量分析。缺失数据方法包括丢弃数据(DROP)、为缺失数据的组添加额外的效应参数(EXTRA)以及混合方法,其中混合概率固定为观察到的类别分数(MIX(obs)),基于浓度数据的似然性(MIX(conc))或观察到的协变量数据和浓度数据的联合似然性(MIX(joint))。我们进行了模拟,以研究在具有相同大小和不平衡分类比例的二元协变量数据集以及具有非随机缺失(MNAR)的数据集的方法中的偏差和不精确性。此外,我们还在两个真实数据集评估了实施的性能和可行性。在缺失率较低(10%)或较高(50%)的情况下,所有方法的性能都非常相似。在不平衡数据集(3:1 协变量分布)和平衡数据集的情况下,性能相似。在 MNAR 情况下,与 EXTRA 相比,MIX 方法在 CL 和协变量效应的估计中显示出更高的偏差。除 DROP 外,所有方法都可应用于真实数据集。在研究的缺失水平下,所有方法的性能都相似,但在 MNAR 的情况下,DROP 和 EXTRA 方法比混合方法提供的偏差更小。然而,EXTRA 与协变量选择的膨胀Ⅰ型错误率相关,而 DROP 则低效地处理数据。